These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16801330)

  • 1. Successful treatment using tacrolimus (FK506) in a patient with TNF receptor-associated periodic syndrome (TRAPS) complicated by monocytic fasciitis.
    Ida H; Aramaki T; Arima K; Origuchi T; Kawakami A; Eguchi K
    Rheumatology (Oxford); 2006 Sep; 45(9):1171-3. PubMed ID: 16801330
    [No Abstract]   [Full Text] [Related]  

  • 2. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
    Simsek I; Kaya A; Erdem H; Pay S; Yenicesu M; Dinc A
    J Nephrol; 2010; 23(1):119-23. PubMed ID: 20091495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocytic fasciitis: a newly recognized clinical feature of tumor necrosis factor receptor dysfunction.
    Hull KM; Wong K; Wood GM; Chu WS; Kastner DL
    Arthritis Rheum; 2002 Aug; 46(8):2189-94. PubMed ID: 12209524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS).
    Jacobelli S; André M; Alexandra JF; Dodé C; Papo T
    Rheumatology (Oxford); 2007 Jul; 46(7):1211-2. PubMed ID: 16935919
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging evidence for persistent subclinical fasciitis and arthritis in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) between febrile attacks.
    Quillinan N; Mohammad A; Mannion G; O'Keeffe D; Bergin D; Coughlan R; McDermott MF; McGonagle D
    Ann Rheum Dis; 2010 Jul; 69(7):1408-9. PubMed ID: 19914902
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial Mediterranean fever successfully treated with etanercept.
    Mor A; Pillinger MH; Kishimoto M; Abeles AM; Livneh A
    J Clin Rheumatol; 2007 Feb; 13(1):38-40. PubMed ID: 17278949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).
    Siebert S; Amos N; Lawson TM
    Rheumatology (Oxford); 2008 Feb; 47(2):228-9. PubMed ID: 18056150
    [No Abstract]   [Full Text] [Related]  

  • 9. Tocilizumab is effective in a familial Mediterranean fever patient complicated with histologically proven recurrent fasciitis and myositis.
    Umeda M; Aramaki T; Fujikawa K; Iwamoto N; Ichinose K; Terada K; Takeo G; Yonemitsu N; Ueki Y; Migita K; Kawakami A
    Int J Rheum Dis; 2017 Nov; 20(11):1868-1871. PubMed ID: 26481326
    [No Abstract]   [Full Text] [Related]  

  • 10. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
    Chang Pan Huo NM; Dankert-Roelse JE; Kwee ML
    Ned Tijdschr Geneeskd; 2006 Dec; 150(49):2711-4. PubMed ID: 17194009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.
    Nedjai B; Hitman GA; Quillinan N; Coughlan RJ; Church L; McDermott MF; Turner MD
    Arthritis Rheum; 2009 Feb; 60(2):619-25. PubMed ID: 19180495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of periodic disease with immuno-depressive agents].
    Mamou H
    Sem Hop; 1970 Jun; 46(29):2030-4. PubMed ID: 4316965
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel markers of inflammation identified in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) by transcriptomic analysis of effects of TRAPS-associated tumor necrosis factor receptor type I mutations in an endothelial cell line.
    Rebelo SL; Amel-Kashipaz MR; Radford PM; Bainbridge SE; Fiets R; Fang J; McDermott EM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2009 Jan; 60(1):269-80. PubMed ID: 19116900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Dutch family with the hereditary periodic fever or tumour necrosis factor receptor-associated periodic syndrome (TRAPS)].
    Bodar EJ; Drenth JP; Simon A; van der Meer JW
    Ned Tijdschr Geneeskd; 2007 Apr; 151(14):836-7; author reply 837. PubMed ID: 17469326
    [No Abstract]   [Full Text] [Related]  

  • 15. [TRAPS syndrome, a rare cause of fever of unknown origin: case report and review of the literature].
    Benucci M; Nenci G; Taccetti G; Rosso A; Cappelletti C
    Ann Ital Med Int; 2005; 20(1):54-7. PubMed ID: 15859396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
    Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dramatic improvement following interleukin 1beta blockade in tumor necrosis factor receptor-1-associated syndrome (TRAPS) resistant to anti-TNF-alpha therapy.
    Sacré K; Brihaye B; Lidove O; Papo T; Pocidalo MA; Cuisset L; Dodé C
    J Rheumatol; 2008 Feb; 35(2):357-8. PubMed ID: 18260167
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute myocarditis and Tumor Necrosis Factor Receptor-Associated Periodic (TRAP) syndrome: first case described and discussion.
    Roubille F; Cayla G; Gahide G; Mourad G; Macia JC
    Eur J Intern Med; 2009 Mar; 20(2):e25-6. PubMed ID: 19327590
    [No Abstract]   [Full Text] [Related]  

  • 19. [TNF receptor-associated periodic syndrome (TRAPS): clinical aspects and physiopathology of a rare familial disease].
    Hentgen V; Reinert P
    Arch Pediatr; 2003 Jan; 10(1):45-53. PubMed ID: 12818781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes.
    Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ
    Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.